Should atorvastatin be taken in the morning or evening, with or without food, and can it be co-administered with amlodipine?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 5, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Atorvastatin Administration Timing and Co-administration with Amlodipine

Atorvastatin can be taken at any time of day (morning or evening), with or without food, and can be safely co-administered with amlodipine without dose adjustment. 1

Timing of Administration

The FDA-approved labeling explicitly states that atorvastatin should be taken "orally once daily at any time of the day, with or without food" 1. This flexibility is based on atorvastatin's long half-life (approximately 14 hours), which distinguishes it from short-acting statins like simvastatin or lovastatin that are more dependent on evening dosing to align with nocturnal cholesterol synthesis.

While some evidence suggests evening dosing of statins may provide marginally better LDL-C lowering (approximately 2.5-3.2 mg/dL difference) 2, this small difference is not clinically meaningful for long-acting statins like atorvastatin. The most important factor is choosing a time that maximizes patient adherence 3. If a patient is more likely to remember their medication in the morning, that is the optimal time for them.

Key Points on Timing:

  • Morning or evening dosing produces equivalent clinical outcomes for atorvastatin 4, 2
  • The slight statistical advantage of evening dosing (3.24 mg/dL greater LDL-C reduction) is clinically insignificant 2
  • Consistency matters more than timing—pick one time and stick with it

Food Considerations

Atorvastatin can be taken with or without food 1. Food does not significantly affect its absorption or efficacy. This provides additional flexibility for patients to integrate the medication into their daily routine in whatever manner best supports adherence.

Co-administration with Amlodipine

Atorvastatin and amlodipine can be safely co-administered without dose restrictions or adjustments. The 2016 American Heart Association scientific statement on statin drug interactions explicitly states: "There is no evidence of significant interaction when amlodipine is coadministered with atorvastatin...and these combination therapies may be considered" 5.

Evidence Supporting Safe Co-administration:

  • No pharmacodynamic interaction exists between atorvastatin and amlodipine—neither drug affects the efficacy or safety of the other 6
  • The RESPOND trial (1,660 patients) demonstrated that combination therapy produced dose-related reductions in both blood pressure and LDL-C without adverse interactions 6
  • Fixed-dose combinations of amlodipine/atorvastatin are FDA-approved and widely used 7, 8
  • Recent real-world data from Taiwan (9,095 patients) showed that fixed-dose combinations of amlodipine 5 mg with atorvastatin 20 mg reduced cardiovascular events by 24% compared to free combinations, likely due to improved adherence 9

Important Contrast with Other Calcium Channel Blockers:

This safety profile is specific to amlodipine. Other calcium channel blockers require caution:

  • Diltiazem and verapamil significantly increase atorvastatin exposure and require dose limitations 5
  • With amlodipine, there are no such restrictions—all doses of atorvastatin (10-80 mg) can be used safely 5

Practical Recommendations

For patients taking both medications:

  1. Take atorvastatin and amlodipine together at the same time each day (morning or evening based on patient preference)
  2. Food is optional—take with or without meals
  3. No dose adjustment needed for either medication
  4. Consider fixed-dose combination products if available to improve adherence 7, 8, 9

Common pitfall to avoid: Do not confuse amlodipine with diltiazem or verapamil. While the latter two calcium channel blockers require atorvastatin dose restrictions, amlodipine does not 5.

The flexibility in timing and food requirements, combined with the safety of co-administration with amlodipine, makes atorvastatin particularly convenient for patients managing multiple cardiovascular risk factors. The priority should be selecting a regimen that the patient will consistently follow 7, 3.

References

Research

Is Time an Important Problem in Management of Hypertension and Hypercholesterolemia by Using an Amlodipine-Atorvastatin Single Pill Combination?

Medical science monitor : international medical journal of experimental and clinical research, 2016

Related Questions

Is it safe to take omeprazole 20 mg in the morning and atorvastatin 80 mg in the evening while also on metformin, losartan, amlodipine, carvedilol, and isosorbide dinitrate?
In a patient with hypertension on amlodipine and chlorthalidone, receiving anti‑androgen therapy for prostate cancer, with LDL cholesterol of 3.02 mmol/L and hemoglobin A1c of 6.0%, should a moderate‑intensity statin be initiated?
What is the optimal time of day to take candesartan?
Should a patient who accidentally took a statin dose in the morning together with amlodipine and aspirin skip the scheduled bedtime dose of the statin?
For a patient who works night shifts, what is the appropriate timing to take statin therapy?
What is the recommended enoxaparin dosing regimen, monitoring strategy, and contraindications for adult patients undergoing chronic hemodialysis?
When is a CT urogram indicated compared to a CT cystogram?
What is the recommended treatment for a widespread cutaneous fungal infection?
Which patients are indicated for both oral estrogen tablets and vaginal estrogen cream?
Can titration of Depakote (valproic acid) cause transient elevations in aspartate aminotransferase (AST) and alanine aminotransferase (ALT)?
What diagnosis and management should be considered for a patient with positive antinuclear antibody (ANA) showing a homogeneous pattern, prolonged partial thromboplastin time (PTT), elevated complement C3, and increased C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.